Archived Content

The content on this page is provided for reference purposes only. This content has not been altered or updated since it was archived.

Drugs

First-Time Generic Drug Approvals - February 2012


 Generic Drug NameGeneric ManufacturerBrand NameApproval Date
1CISATRACURIUM BESYLATE INJECTION, 2 MG (BASE)/ML; PACKAGED IN 20 MG (BASE)/10 ML MULTIPLE-DOSE VIALS     SANDOZ INC.NIMBEX INJECTION

2/3/2012 

2CISATRACURIUM BESYLATE INJECTION, (PRESERVATIVE FREE) 10 MG (BASE)/ML PACKAGED IN 200 MG (BASE)/20 ML; AND 2 MG (BASE)/ML PACKAGED IN 100 MG (BASE)/5 ML SINGLE-DOSE VIALS    SANDOZ INC.NIMBEX INJECTION2/3/2012 
3TIZANIDINE HYDROCHLORIDE CAPSULES, 2 MG (BASE), 4 MG (BASE) AND 6 MG (BASE) APOTEX INC.ZANAFLEX CAPSULES2/3/2012 
4DOXYCYCLINE HYCLATE DELAYED-RELEASE TABLETS USP, 150 MG (BASE)       MYLAN PHARMACEUTICALS INC.DORYX DELAYED-RELEASE TABLETS2/8/2012 
5PROGESTERONE CAPSULES, 100 MG AND 200 MG      TEVA PHARMACEUTICALS USAPROMETRIUM CAPSULES2/29/2012 

 

 

Page Last Updated: 08/13/2015
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.